Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

Catherine Cordonnier, Cécile Pautas, Sébastien Maury, +12

Clinical Infectious Diseases

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Claude Preudhomme, Joëlle Guilhot, Franck E. Nicolini, +20

New England Journal of Medicine

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop, +135

The Lancet

Hematological MalignancyCell TherapyTransplantationMedicineHematology +7

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Emmanuel Bachy, John F. Seymour, Pierre Feugier, +27

Journal of Clinical Oncology

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

Bruno Chetaille, François Bertucci, Pascal Finetti, +14

Blood

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Bertrand Godeau, Raphaël Porcher, Olivier Fain, +15

Blood

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

Thorsten Braun, Raphaël Itzykson, Aline Renneville, +21

Blood

Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia Group

Lionel Adès, Sylvie Chevret, Emmanuel Raffoux, +17

Journal of Clinical Oncology

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

Lionel Adès, Miguel Á. Sanz, Sylvie Chevret, +26

Blood

The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies

Anne Bergeron, Raphaël Porcher, Annie Sulahian, +12

Blood